Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Portola Pharmaceuticals Inc. PTLA

Healthcare Biotechnology
"Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of... see more

Recent & Breaking News (NDAQ:PTLA)

DEADLINE ALERT for EXC, TCNNF, WBAI, and PTLA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire February 12, 2020

ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Portola Pharmaceuticals, Inc. Investors of Important March 16th Deadline in Securities Class Action - PTLA

GlobeNewswire February 12, 2020

CLASS ACTION UPDATE for FSCT, PTLA and WBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA February 12, 2020

INVESTOR ALERT - Portola Pharmaceuticals Inc. (PTLA) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: March 16, 2020

GlobeNewswire February 12, 2020

Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020

PR Newswire February 12, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, PTLA and GERN

ACCESSWIRE IA February 11, 2020

Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Actions Against Portola Pharmaceuticals, Inc. (PTLA)

PR Newswire February 11, 2020

Portola Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Portola Pharmaceuticals, Inc. To Contact The Firm

Newsfile February 11, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GDOT, PTLA and WBK

ACCESSWIRE IA February 10, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA

GlobeNewswire February 10, 2020

SHAREHOLDER ALERT: FSCT PTLA QD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA February 10, 2020

Shareholder Alert: Robbins LLP Reminds Investors Portola Pharmaceuticals, Inc. (PTLA) Sued for Misleading Shareholders

Business Wire February 10, 2020

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceuticals, Inc. (PTLA)

GlobeNewswire February 10, 2020

CLASS ACTION UPDATE for FSCT, PTLA and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA February 10, 2020

PTLA DEADLINE NOTICE: Pawar Law Group Reminds Investors of March 16 Deadline in Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. - PTLA

GlobeNewswire February 10, 2020

Saxena White P.A. Files New Securities Fraud Class Action Complaint Against Portola Pharmaceuticals, Inc. with Expanded Class Period

GlobeNewswire February 7, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GDOT, PTLA and QD

ACCESSWIRE IA February 7, 2020

CLASS ACTION UPDATE for ADMS, GDOT and PTLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA February 7, 2020

Wolf Haldenstein Reminds Investors In Portola Pharmaceuticals, Inc. That A Securities Class Action Has Been Filed

PR Newswire February 6, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PTLA, GERN and BYND

ACCESSWIRE IA February 6, 2020